National and regional asthma programmes in Europe

European Respiratory Review

Volumn 24, Issue 137, 2015, Pages 474-483

  Selroos, Olof ^a   Kupczyk, Maciej ^b   Kuna, Piotr ^b   Łacwik, Piotr ^b   Bousquet, Jean ^c   Brennan, David ^d   Palkonen, Susanna ^d   Contreras, Javier ^e   FitzGerald, Mark ^f   Hedlin, Gunilla ^g   Johnston, Sebastian L ^h   Louis, Renaud ⁱ   Metcalf, Leanne ^j   Walker, Samantha ^j   Moreno Galdó, Antonio ^k   Papadopoulos, Nikolaos G ^l   Rosado Pinto, José ^m   Powell, Pippa ⁿ   Haahtela, Tari ^o  

^a Selroos Medical Consulting (Semeco AB)   (Sweden)

^b Medical University of Lodz ^*  (Poland)

^c INSERM   (France)

^d EFA European Federation of Allergy and Airways Diseases Patients' Associations   (Belgium)

^e National Federation of Respiratory Disease Associations (FENAER)   (Spain)

^f Institute for Heart and Lung Health   (Canada)

^g KAROLINSKA INSTITUTE   (Sweden)

^h NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

ⁱ UNIVERSITY OF LIÈGE   (Belgium)

^j ASTHMA UK   (United Kingdom)

^k HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^l UNIVERSITY OF ATHENS   (Greece)

^m HOSPITAL DA LUZ   (Portugal)

ⁿ European Lung Foundation   (United Kingdom)

^o HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ASTHMA; DISABILITY; DISEASE SEVERITY; EUROPE; HEALTH CARE; HEALTH PROGRAM; HOSPITALIZATION; HUMAN; MEDICAL LEAVE; MORBIDITY; MORTALITY; PREVALENCE; PRIMARY MEDICAL CARE; QUALITY OF LIFE; RESOURCE ALLOCATION; REVIEW; SELF CARE; SPAIN; SYSTEMATIC REVIEW; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEALTH CARE QUALITY; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; PROGRAM DEVELOPMENT; PUBLIC HEALTH; STANDARDS; TIME FACTOR; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME;

ASTHMA; EUROPE; HEALTH SERVICES ACCESSIBILITY; HUMANS; NATIONAL HEALTH PROGRAMS; PRACTICE GUIDELINES AS TOPIC; PROGRAM DEVELOPMENT; QUALITY IMPROVEMENT; QUALITY INDICATORS, HEALTH CARE; REGIONAL HEALTH PLANNING; TIME FACTORS; TREATMENT OUTCOME;

EID: 84940643725     PISSN: 09059180     EISSN: 16000617     Source Type: Journal    
DOI: 10.1183/16000617.00008114     Document Type: Review

References (76)

1. Gibson J, Loddenkemper R, Sibille Y, et al., eds. The European Lung White Book. Respiratory Health and Disease in Europe. Sheffield, European Respiratory Society, 2013.
2. World Health Organization. Chronic respiratory diseases. Asthma. www.who.int/respiratory/asthma Date last updated: 2013. Date last accessed: February 21, 2014.
3. van den Akker-van Marle ME, Bruil J, Detmar SB. Evaluation of cost of disease: assessing the burden to society of asthma in children in the European Union. Allergy 2005; 60: 140-149.
4. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. www.ginasthma.org/local/ uploads/files/GINA_Report_2014_Aug12.pdf Date last updated: 2014. Date last accessed: April 20, 2014.
5. Bahadori K, Doyle-Waters MM, Marra C, et al. Economic burden of asthma: a systematic review. BMC Pulm Med 2009; 9: 24.
6. Gibson J, Loddenkemper R, Sibille Y, et al., eds. Lung Health in Europe. Facts and Figures. Sheffield, European Respiratory Society/European Lung Foundation, 2013.
7. Haahtela T, Klaukka T, Koskela K, et al. Asthma programme in Finland: a community problem needs community solutions. Thorax 2001; 56: 806-814.
8. Haahtela T, Tuomisto LE, Pietinalho A, et al. A 10 year asthma programme in Finland: major change for the better. Thorax 2006; 61: 663-670.
9. Mortensen J, Renda A. Asthma in the EU. Towards better management and regulation of a public health issue. Brussels, Centre for European Policy Studies, 2007.
10. Manning P, Greally P, Shanahan E. Asthma control and management: a patient’s perspective. Ir Med J 2005; 98: 231-232.
11. Asthma Society of Ireland. Time to take action on asthma in Ireland. www.asthma.ie/news/time-take-actionasthma-ireland. Date last updated: May 6, 2015. Date last accessed: June 8, 2015.
12. Laurendi G, Mele S, Centanni S, et al. Global alliance against chronic respiratory diseases in Italy (GARD-Italy): strategy and activities. Respir Med 2012; 106: 1-8.
13. World Health Organization. Global Alliance Against Chronic Respiratory Diseases (GARD). Report from the 8th general meeting. Chapter 4.2 The Netherlands. WHO/NMH/MND/CPM/13.3. Geneva, WHO, 2013.
14. Stelmach W, Majak P, Jerzynska J, et al. Early effects of asthma prevention program on asthma diagnosis and hospitalization in urban population of Poland. Allergy 2005; 60: 606-610.
15. Kupczyk M, Haahtela T, Cruz AA, et al. Reduction of asthma burden is possible through national asthma plans. Allergy 2010; 65: 415-419.
16. Kuna P, Kupczyk M, Kupryś-Lipińska I. POLASTMA - the Polish National Programme of Early Diagnostics and Treatment of Asthma. Pneumonol Alergol Pol 2014; 82: 597-607.
17. Bugalho de Almeida A, Covas A, Prates L, et al. Asthma hospital admission and mortality in mainland Portugal 2000-2007. Rev Portuguesa Pneumol 2009; 15: 367-383.
18. Fonseca Antunes A, Bárbara C, Melo Gomes E. Portuguese National Programme for Respiratory Diseases 2012/ 2016. Lisbon, DGS, 2012.
19. Lalloo UG, Walters RD, Adachi M, et al. Asthma programmes in diverse regions of the world: challenges, successes and lessons learnt. Int J Tuberc Lung Dis 2011; 15: 1574-1587.
20. Yorgancioğlu A, Yardim N, Ergün P, et al. Integration of GARD Turkey national programme with other non-communicable diseases plans in Turkey. Tüberküloz ve Toraks Dergisi 2010; 58: 213-228.
21. Sekerel BE, Saraclar Y, Ones U, et al. Childhood asthma perception in Turkey under real-life environment (CAPTURE) study. Pediatr Allergy Immunol 2001; 12: 266-273.
22. Beyhun NE, Soyer OU, Kuyucu S, et al. A multi-center survey of childhood asthma in Turkey - I: the cost and its determinants. Pediatr Allergy Immunol 2009; 20: 72-80.
23. Soyer OU, Beyhun NE, Demir E, et al. A multicenter survey of childhood asthma in Turkey. II: utilization of asthma drugs, control levels and their determinants. Pediatr Allergy Immunol 2009; 20: 172-179.
24. Turktas H, Mungan D, Uysal MA, et al. Determinants of asthma control in tertiary level in Turkey: a cross-sectional multicenter survey. J Asthma 2010; 47: 557-562.
25. Helse- og Omsorgsdepartementet. National strategy for prevention and treatment of asthma and allergy diseases 2008-2012 (in Norwegian). www.regjeringen.no/nb/tema/helse-og-omsorg/folkehelse/nasjonal-strategi-forforebygging- og-beh/id510004/.
26. Schleich F, Brusselle G, Louis R, et al. Heterogeneity of phenotypes in severe asthmatics. The Belgian severe asthma registry (BSAR). Respir Med 2014; 108: 1723-1732.
27. National Asthma Council Australia. Australian Asthma Handbook. www.nationalasthma.org.au/handbook. Date last updated: April 2015. Date last accessed: June 9, 2015.
28. McCaul KA, Wakefield MA, Roder DM, et al. Trends in hospital readmission for asthma: has the Australian National Asthma Campaign had an effect? Med J Austr 2000; 172: 62-66.
29. Boulet LP, Dorval E, Labrecque M, et al. Towards excellence in asthma management: final report of an eight-year program aimed at reducing care gaps in asthma management in Quebec. Can Respir J 2008; 15: 302-310.
30. To T, Cicutto L, Degani N, et al. Can a community evidence-based asthma care program improve clinical outcomes? A longitudinal study. Med Care 2008; 46: 1257-1266.
31. Chong PN, Tan NC, Lim TK. Impact of the Singapore national asthma program (SNAP) on preventor-reliever prescription ratio in polyclinics. Ann Acad Med Singapore 2008; 37: 114-117.
32. Cruz AA, Souza-Machado A, Franco R, et al. The impact of a program for control of asthma in a low-income setting. World Allergy Organ J 2010; 3: 167-174.
33. Soto-Martínez M, Avila L, Soto N, et al. Trends in hospitalizations and mortality from asthma in Costa Rica over a 12- to 15-year period. J Allergy Clin Immunol Pract 2014; 2: 85-90.
34. Foliaki S, Fakakovikaetau T, D’Souza W, et al. Reduction in asthma morbidity following a community-based asthma self-management programme in Tonga. Int J Tuberc Lung Dis 2009; 13: 142-147.
35. Partridge MR. Translating research into practice: how are guidelines implemented? Eur Respir J 2003; 21: Suppl. 39, 23s-29s.
36. Harrison MB, Légaré F, Graham ID, et al. Adapting clinical practice guidelines to local context and assessing barriers to their use. CMAJ 2010; 182: E78-E84.
37. Baiardini I, Braido F, Bonini M, et al. Why do doctors and patients not follow guidelines? Curr Opin Allergy Clin Immunol 2009; 9: 228-233.
38. Boulet LP, FitzGerald JM, Levy ML, et al. A guide to the translation of the Global Initiative for Asthma (GINA) strategy into improved care. Eur Respir J 2012; 39: 1220-1229.
39. Haahtela T, Laitinen LA, Koskela K, et al. Asthma programme in Finland 1994-2004. Report of a working group. Clin Exp Allergy 1996; 26: 1-24.
40. Haahtela T, von Hertzen L, Mäkelä M, et al. Finnish Allergy Programme 2008-2018 - time to act and change the course. Allergy 2008; 63: 634-645.
41. Bousquet J, Dahl R, Khaltaev N. Global Alliance against Chronic Respiratory Diseases. Eur Respir J 2007; 29: 233-239.
42. Yorgancioğlu A, Cruz AA, Bousquet J, et al. The Global Alliance against Respiratory Diseases (GARD) country report. Prim Care Respir J 2014; 23: 98-101.
43. Asher MI, Montefort S, Björkstén B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet 2006; 368: 733-743.
44. Pearce N, Air-Khaled N, Beasley R, et al. Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2007; 62: 758-766.
45. Lai CK, Beasley R, Crane J, et al. Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2009; 64: 476-483.
46. Asher MI, Keil U, Anderson HR, et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J 1995; 8: 483-491.
47. International Union Against Tuberculosis and Lung Disease. The Global Asthma Report 2011. Paris, The International Union Against Tuberculosis and Lung Disease, 2011. www.globalasthmareport.org/2011/.
48. Council of the European Union. Council conclusions on prevention, early diagnosis and treatment of chronic respiratory diseases in children. www.consilium.europa.eu/uedocs/cms_Data/docs/pressdata/en/lsa/126522.pdf Date last updated: December 1-2, 2011. Date last accessed: August 28, 2014.
49. Samolinski B, Fronczak A, Kuna P, et al. Prevention and control of childhood asthma and allergy in the EU from the public health point of view: Polish Presidency of the European Union. Allergy 2012; 67: 726-731.
50. Ring N, Pinnock H, Wilson C, et al. Understanding what asthma plans mean: a linguistic analysis of terminology used in published texts. Prim Care Respir J 2011; 20: 170-177.
51. The Center for Managing Chronic Disease. Asthma Health Outcomes Project. Asthma programs with an environmental component: a review of the field and lessons for success. Ann Arbor, Center for Managing Chronic Disease, 2007.
52. Erhola M, Mäkinen R, Koskela K, et al. The asthma programme of Finland: an evaluation survey in primary health care. Int J Tuberc Lung Dis 2003; 7: 592-598.
53. Tuomisto L, Erhola M, Kaila M, et al. Asthma programme in Finland: high consensus between general practitioners and pulmonologists on the content of an asthma referral letter. Respir Med 2004; 13: 205-210.
54. Tuomisto LE, Erhola M, Luukkaala T, et al. Asthma programme in Finland: did the use of secondary care resources become more rational? Respir Med 2010; 104: 957-965.
55. Reissell E, Herse F, Väänänen J, et al. The price of asthma in Finland 1987-2005 - costs and financial benefits of treating a chronic disease. Finn Med J 2010; 65: 811-816.
56. Kauppi P, Linna M, Hämäläinen P, et al. Hospital treatment and emergency visits for asthma as quality indicators. Finn Med J 2010; 65: 3497-3502.
57. Kainu A, Pallasaho P, Piirilä P, et al. Increase in prevalence of physician-diagnosed asthma in Helsinki during the Finnish Asthma Programme: improved recognition of asthma in primary care? A cross-sectional cohort study. Prim Care Respir J 2013; 22: 64-71.
58. Kauppi P, Linna M, Martikainen J, et al. Follow-up of the Finnish Asthma Programme 2000-2010: reduction of hospital burden needs risk group rethinking. Thorax 2013; 68: 292-293.
59. Jantunen J, Kauppi P, Linna M, et al. Asthma and allergy costs in Finland are high but decreasing. Finn Med J 2014; 69: 641-646.
60. Kauppi P, Peura S, Salimäki J, et al. Reduced severity and improved control of self-reported asthma in Finland during 2001-2010. Asia Pac Allergy 2015; 5: 32-39.
61. Barcala FJ, Viñas JA, Cuadrado LV, et al. Trends in hospital admissions due to asthma in north-west Spain from 1995 to 2007. Allergol Immunopathol 2010; 38: 254-258.
62. Pascal L, Fuhrman C, Durif L, et al. Trends in hospital admissions for asthma in France, 1998-2002. Rev Mal Respir 2007; 24: 581-590.
63. Bjerg A, Ekerljung L, Middelveld R, et al. Increased prevalence of symptoms of rhinitis but not of asthma between 1990 and 2008 in Swedish adults: comparisons of the ECRHS and GA2LEN surveys. PLoS One 2011; 6: e16802.
64. Läkemedelsverket. Pharmacological treatment of asthma. Treatment recommendations (in Swedish). Date last updated: 2007. Date last accessed: June 12, 2015. https://lakemedelsverket.se/upload/halso-och-sjukvard/behandlingsrekommendationer/astma2007_rek_bokm%C3%A4rken.pdf.
65. Dansk Lungemedicinsk Selskab. Asthma: Treatment. Revision 2013. www.lungemedicin.dk/fagligt/39-astma-behandling/ file.html.
66. Norges Astma- og Allergiforbund. Facts about asthma 2006 (in Norwegian). Date last updated: June 12, 2014. Date last accessed: August 28, 2014. www.naaf.no/no/astma/fakta_om_astma/.
67. Ekerljung L, Bjerg A, Bossios A, et al. Five-fold increase in use of inhaled corticosteroids over 18 years in the general adult population in West Sweden. Respir Med 2014; 108: 685-693.
68. Janson C, de Marco R, Accordini S, et al. Changes in the use of anti-asthmatic medication in an international cohort. Eur Respir J 2005; 26: 1047-1055.
69. EUROSTAT. European shortlist: cause of death statistics. http://epp.eurostat.ec.europa.eu/statistics_explained/index.php/Glossary:European_shortlist_of_causes_of_death Date last updated: April, 2014. Date last accessed: June 2, 2014.
70. Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients’ care. Lancet 2003; 362: 1225-1230.
71. Fitzgerald JM, Quon B. The impact of asthma guidelines. Lancet 2010; 376: 751-753.
72. Lahdensuo A, Haahtela T, Herrala J, et al. Randomised comparison of self management and traditional treatment of asthma over one year. BMJ 1996; 312: 748-752.
73. Lahdensuo A, Haahtela T, Herrala J, et al. Randomised comparison of cost effectiveness of guided self management and traditional treatment of asthma in Finland. BMJ 1998; 316: 1138-1139.
74. Gibson PG, Powell H, Coughlan J, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev 2003, 1: CD001117.
75. Mihaltan F, Nemes R, Ionescu A. Effectiveness of continuity in “World Day of COPD” awareness campaign on case finding for COPD in target populations. Eur Respir J 2011; 38: Suppl 55, s186.
76. Tan WC, Aït-Khaled N. Dissemination and implementation of guidelines for the treatment of asthma. Int J Tuberc Lung Dis 2006; 10: 710-716.